» Articles » PMID: 16040397

Methods for Isolating Circulating Epithelial Cells and Criteria for Their Classification As Carcinoma Cells

Overview
Journal Cytotherapy
Publisher Elsevier
Date 2005 Jul 26
PMID 16040397
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Novel assay methods developed for the isolation and characterization of circulating tumor cells (CTC) of epithelial origin offer the potential of markers for the non-invasive gathering of clinical information relevant to the diagnosis, evolution and treatment of carcinoma. Of the numerous techniques currently used to analyze CTC, slide-based assays are perhaps the most common. While traditional combined immunocytochemical/brightfield microscopy systems continue to be the most frequently employed, fluorescence-based analysis is gaining in importance. This is partly because fluorescence microscopy analysis of slide-mounted CTC can provide simultaneously cytogenetic as well as morphologic and multiple phenotypic information. In particular, fluorescence microscopy analysis of slide-mounted CTC can accurately determine genetic changes at the chromosomal level in patients with recurrent disease. More importantly, by identifying genetic aberrations in CTC, it becomes possible to choose those patients most likely to benefit from a given treatment. The potential of this technique has already been demonstrated by employing fluorescence in situ hybridization (FISH) methods to measure expression of the HER2/neu gene in tissue from patients with breast carcinoma for the specific purpose of identifying those patients most likely to respond to Trastuzumab targeted therapy. Here, we review the major methodologies used in the preparation and analysis of the slide-based assays.

Citing Articles

The capture of circulating tumor cells by Labyrinth system as a tool for early stage lung cancer detection.

Jin P, Li H, Xie M, Tang J, Zou S, Wang R Front Oncol. 2024; 14:1474015.

PMID: 39540154 PMC: 11557529. DOI: 10.3389/fonc.2024.1474015.


Harnessing the power of Microscale AcoustoFluidics: A perspective based on BAW cancer diagnostics.

Harshbarger C Biomicrofluidics. 2024; 18(1):011304.

PMID: 38434238 PMC: 10907075. DOI: 10.1063/5.0180158.


CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.

Ffrench B, Kashdan E, Huang Y, Spillane C, Cocchiglia S, Charmsaz S Heliyon. 2023; 9(1):e13044.

PMID: 36747925 PMC: 9898658. DOI: 10.1016/j.heliyon.2023.e13044.


Comparison of sample preparation methods for rare cell isolation in microfluidic devices.

Varillas J, Chen K, Dopico P, Zhang J, George T, Fan Z Can J Chem. 2022; 100(7):512-519.

PMID: 36338875 PMC: 9635407. DOI: 10.1139/cjc-2021-0229.


Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells.

Tieng F, Abu N, Nasir S, Lee L, Mutalib N Diagnostics (Basel). 2021; 11(11).

PMID: 34829483 PMC: 8618170. DOI: 10.3390/diagnostics11112136.